Company intelligence / Profile preview

SUPERGENICS LIFE SCIENCE SDN. BHD.

Subang Jaya, Selangor, Malaysiafacebook.com ↗

Ownership: Private
Development stage: Commercial

Overview

Supergenics has achieved commercial revenue from licensing its technology to produce wellness products such as stem cell derivatives for anti-aging. The company is also developing new technologies involving natural killer cells and laboratory-developed stem cells in gel form. It operates advanced GMP-compliant facilities and provides integrated cleanroom solutions primarily used in life sciences fields including clinical trials, assisted reproduction, and stem cell processing.

Therapeutic areas: OtherWomen's Health
Modalities: Mesenchymal stem cells (MSC)Exosome-based therapyNatural killer cell therapy
Industry: Biotech

Drug pipeline

1 asset

Wharton-Jelly mesenchymal stem cells

Beyond the preview

Go deeper on SUPERGENICS LIFE SCIENCE SDN. BHD..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUPERGENICS LIFE SCIENCE SDN. BHD..

Explore the full profile